Journal rankings · indicator year 2022
Choose a field to open its ranking, or a journal to find its row in its subfield’s list.
Subfield ranking · 2022
Immunology journal rankings 2022
88 ranked journals · Subfield in Immunology and Microbiology
Immunology has 88 ranked journals in 2022. The median journal has an OJR of 0.97, below the world average of 1.00, up 0.03 on 2021; Q1 starts at OJR 1.38. The top three are Immunity, Nature Immunology, and Science Immunology.
Ranks and citation indicators: 2022. Journal access status and listed APC: source snapshot September 23, 2026.
Journals whose main subfield sits in this category and that published at least 30 citable documents (articles, reviews and conference papers) in 2019–2021, the window the 2022 score is computed on.
The OpenJournalRank Indicator (OJR) is a free, publicly available metric of a journal’s field-normalized citation impact, computed from open OpenAlex citation data. It compares citations to a journal’s papers from the previous three years with the world average for papers of the same subfield, year and type, so 1.00 is the world average and values can be compared across fields. It is computed with the NCI3 method.
The middle OJR among ranked journals in this category: half score higher, half lower. 1.00 is the world average for papers of the same subfield, year and type.
The dot is this category, the solid tick is the median of all ranked journals and the dashed line is the world average.
Share of ranked journals in this category that are fully open access, so every paper is free to read. Hybrid journals, which sell subscriptions and open single papers for a fee, are not counted.
Median list price of the article processing charge, in US dollars, among ranked journals in this category that list a price above zero. Journals with a listed APC of $0 and journals with no known price are left out of this median. The At a glance table below gives a second median that includes the $0 prices.
Subfields of Immunology and Microbiology (5)
88 ranked journals
Filters
Rank is the position by OJR within the list on screen; 1 is the highest. | OJR is field-normalized 3-year citation impact: 1.00 is the world average for papers of the same subfield, year and type, so values compare across fields. The badge is the journal’s quartile in this list. | Citations per paper over a two-year window, counted from OpenAlex. It is not field-normalized, so compare it only between journals of the same field. ▲ or ▼ is the change from 2021. This is OpenJournalRank’s own count, not Clarivate’s Journal Impact Factor. | Citable documents (articles, reviews and conference papers) published in 2019–2021, the window the 2022 OJR is computed on. A journal needs at least 30 to be ranked. | Share of the journal’s 2019–2021 papers that are free to read in any open-access form. The green OA tag next to a title marks a fully open-access journal. | List price of the article processing charge in US dollars. “$0 listed” means the listed price is zero; a dash means no price is listed. | The line is the journal’s OJR from 2013 to 2022. | Compare |
|---|---|---|---|---|---|---|---|
1ImmunityCell Press · United States | 5.82Q1 | 23.64 7.19 down from 2021 | 745 | 100% | $10,400 | ||
2Nature ImmunologyNature Portfolio · United States | 4.51Q1 | 19.75 0.15 down from 2021 | 687 | 56% | $12,690 | ||
3Science ImmunologyAmerican Association for the Advancement of Science · United States | 4.33Q1 | 21.35 3.71 down from 2021 | 425 | 64% | — | ||
4Nature reviews. ImmunologyNature Portfolio · United Kingdom | 4.23Q1 | 34.32 4.36 down from 2021 | 544 | 47% | — | ||
5Journal of AutoimmunityElsevier BV · United Kingdom | 3.54Q1 | 16.87 1.26 down from 2021 | 356 | 57% | $5,420 | ||
6Clinical Reviews in Allergy & ImmunologySpringer Nature · United States | 3.31Q1 | 10.54 0.51 down from 2021 | 173 | 50% | $5,490 | ||
7The Journal of Experimental MedicineRockefeller University Press · United States | 3.23Q1 | 13.06 1.98 down from 2021 | 839 | 100% | — | ||
8Seminars in ImmunopathologySpringer Science+Business Media · Germany | 3.11Q1 | 10.39 1.58 down from 2021 | 162 | 87% | $3,790 | ||
9Cellular and Molecular ImmunologySpringer Nature · China | 2.97Q1 | 15.09 0.38 up from 2021 | 588 | 99% | $5,190 | ||
10Journal of Allergy and Clinical ImmunologyElsevier BV · United States | 2.63Q1 | 11.29 0.53 down from 2021 | 1,367 | 33% | $4,900 | ||
11Annual Review of ImmunologyAnnual Reviews · United States | 2.56Q1 | 33.00 1.72 down from 2021 | 77 | 74% | — | ||
12Seminars in ImmunologyElsevier BV · United States | 2.47Q1 | 8.70 1.91 down from 2021 | 162 | 63% | $4,370 | ||
13Immunity & AgeingOABioMed Central · United Kingdom | 2.39Q1 | 9.17 1.99 down from 2021 | 111 | 100% | $3,190 | ||
14Frontiers in ImmunologyOAFrontiers Media · Switzerland | 2.09Q1 | 8.25 1.63 down from 2021 | 12,180 | 100% | $3,801 | ||
15Mucosal ImmunologyOAElsevier BV · United States | 2.01Q1 | 8.01 0.91 down from 2021 | 329 | 100% | $4,370 | ||
16Clinical ImmunologyElsevier BV · Netherlands | 1.78Q1 | 8.96 1.22 down from 2021 | 544 | 40% | $4,400 | ||
17International Journal of InflammationOAHindawi Publishing Corporation · United Kingdom | 1.73Q1 | 2.46 6.32 down from 2021 | 33 | 100% | $1,000 | ||
18Inflammation ResearchSpringer Science+Business Media · Switzerland | 1.67Q1 | 7.42 0.19 down from 2021 | 307 | 42% | $4,790 | ||
19ImmunologyWiley · United Kingdom | 1.56Q1 | 6.00 0.97 down from 2021 | 357 | 67% | $5,330 | ||
20Clinical & Translational ImmunologyOAWiley · Australia | 1.51Q1 | 6.33 0.59 down from 2021 | 302 | 100% | $3,070 | ||
21BioDrugsAdis, Springer Healthcare · Switzerland | 1.46Q1 | 6.62 1.74 down from 2021 | 172 | 70% | $5,190 | ||
22Immune NetworkOASouth Korea | 1.38Q1 | 6.81 0.57 up from 2021 | 140 | 100% | — | ||
23Journal of Leukocyte BiologyOxford University Press · United States | 1.37Q2 | 5.75 0.03 down from 2021 | 704 | 49% | $3,800 | ||
24Genes and ImmunitySpringer Nature · United States | 1.34Q2 | 5.96 0.25 down from 2021 | 100 | 63% | $3,190 | ||
25Journal of Innate ImmunityOAKarger Publishers · Switzerland | 1.31Q2 | 4.21 2.07 down from 2021 | 125 | 100% | $3,590 | ||
26Expert Opinion on Biological TherapyTaylor & Francis · United Kingdom | 1.30Q2 | 4.49 0.90 down from 2021 | 430 | 44% | — | ||
27International ImmunologyOxford University Press · United Kingdom | 1.25Q2 | 4.03 0.53 down from 2021 | 268 | 61% | $3,530 | ||
28The AAPS JournalSpringer Science+Business Media · United States | 1.24Q2 | 4.92 0.94 up from 2021 | 362 | 54% | $5,090 | ||
29Trends in ImmunologyElsevier BV · United Kingdom | 1.22Q2 | 10.15 3.46 down from 2021 | 391 | 60% | $7,030 | ||
30Clinical & Experimental ImmunologyOxford University Press · United Kingdom | 1.20Q2 | 4.27 1.26 down from 2021 | 422 | 99% | $3,816 | ||
31International Reviews of ImmunologyTaylor & Francis · United States | 1.15Q2 | 5.26 0.01 up from 2021 | 112 | 32% | — | ||
32Cytokine & Growth Factor ReviewsElsevier BV · United Kingdom | 1.13Q2 | 15.75 2.27 down from 2021 | 173 | 35% | $4,900 | ||
33Immunologic ResearchSpringer Science+Business Media · United States | 1.11Q2 | 5.11 0.10 down from 2021 | 180 | 47% | $2,890 | ||
34CytokineElsevier BV · United Kingdom | 1.11Q2 | 4.10 0.19 up from 2021 | 901 | 30% | $3,220 | ||
35Journal of Clinical ImmunologySpringer Science+Business Media · United States | 1.11Q2 | 5.62 0.15 up from 2021 | 571 | 59% | $4,990 | ||
36The Journal of ImmunologyAmerican Association of Immunologists · United States | 1.07Q2 | 4.35 0.79 down from 2021 | 1,856 | 19% | $3,500 | ||
37Cellular ImmunologyElsevier BV · Netherlands | 1.04Q2 | 4.39 0.60 up from 2021 | 329 | 37% | $3,550 | ||
38Fish & Shellfish ImmunologyElsevier BV · United Kingdom | 1.04Q2 | 5.00 0.46 up from 2021 | 1,902 | 12% | $4,330 | ||
39Drugs in R&DOAAdis, Springer Healthcare · New Zealand | 1.03Q2 | 3.47 0.19 down from 2021 | 111 | 100% | $3,490 | ||
40Immunology LettersElsevier BV · Netherlands | 1.03Q2 | 4.68 0.70 up from 2021 | 359 | 48% | $3,290 | ||
41American Journal of Reproductive ImmunologyWiley · United Kingdom | 1.03Q2 | 4.04 0.39 up from 2021 | 368 | 33% | $4,460 | ||
42European Journal of ImmunologyWiley · Germany | 1.02Q2 | 4.31 0.31 down from 2021 | 718 | 66% | $4,550 | ||
43Molecular ImmunologyElsevier BV · Netherlands | 1.02Q2 | 3.67 0.39 down from 2021 | 803 | 20% | $3,340 | ||
44Journal of ImmunotoxicologyOAInforma · United States | 1.00Q2 | 4.29 0.76 up from 2021 | 56 | 100% | $2,306 | ||
45BMC ImmunologyOABioMed Central · United Kingdom | 0.94Q3 | 3.49 0.36 down from 2021 | 189 | 100% | $3,090 | ||
46Journal of Reproductive ImmunologyElsevier BV · Netherlands | 0.91Q3 | 3.41 0.61 down from 2021 | 325 | 21% | $3,690 | ||
47Immunology and Cell BiologyWiley · Australia | 0.89Q3 | 2.81 1.45 down from 2021 | 259 | 60% | $3,750 | ||
48Current Protocols in ImmunologyWiley · United States | 0.87Q3 | 4.21 0.87 up from 2021 | 42 | — | $5,050 | ||
49Immunotherapy AdvancesOAOxford University Press · United Kingdom | 0.86Q3 | 3.39 1.94 up from 2021 | 38 | 100% | $3,053 | ||
50Scandinavian Journal of ImmunologyWiley · United Kingdom | 0.86Q3 | 3.81 0.18 up from 2021 | 339 | 39% | $4,480 |
Subfields of Immunology and Microbiology, with Immunology highlighted.
Journals
Citations made in 2022. Corpus-wide, 89.5% of core-journal articles and reviews published that year have at least one matched reference; the share varies by journal and field.
31 additional Immunology journals with metrics are unranked under this release’s eligibility rules: a journal needs at least 30 citable documents in 2019–2021, at least 80% of them with a subfield, and a positive world-average expectation. Ranks are within the whole category; filters hide rows without re-ranking. OJR excludes self-citations.
At a glance
Indicator year: 2022. Publication window: 2019–2021. How these summaries are calculated
- Ranked journals
- 88
- Window papers (baseline)
- 81,615 +12.7% from indicator year 2019
- Median OJR
- 0.967 -0.4% from indicator year 2019
- Rising journals (2025)
- 5
Window papers are the baseline paper population: citable papers (articles, reviews and conference papers) from 2019–2021 in all journals of the world-average baseline, including non-core journals, counted by each paper’s own subfield. They are not the papers of the ranked journals alone.
| Measure | Year series | 2000 | 2001 | 2002 | 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Ranked journals | 56 | 59 | 63 | 65 | 62 | 64 | 68 | 72 | 71 | 74 | 76 | 79 | 81 | 86 | 83 | 88 | 90 | 96 | 94 | 90 | 92 | 87 | 88 | 88 | 88 | 86 | |
| Window papers (baseline) | 33,673 | 35,811 | 37,963 | 40,362 | 42,065 | 44,849 | 47,600 | 50,960 | 53,923 | 57,726 | 63,072 | 65,596 | 67,601 | 67,579 | 70,684 | 72,624 | 73,354 | 72,790 | 72,098 | 72,447 | 74,045 | 77,362 | 81,615 | 83,779 | 84,353 | 84,391 | |
| Median OJR | 0.72 | 0.78 | 0.834 | 0.82 | 0.830 | 0.88 | 0.89 | 0.959 | 1.002 | 1.15 | 1.100 | 1.09 | 1.096 | 1.04 | 1.08 | 1.06 | 1.05 | 0.95 | 0.921 | 0.970 | 0.931 | 0.932 | 0.967 | 0.956 | 0.922 | 0.87 |
How to read these rankings
- OJR, the OpenJournalRank Indicator
- A field-normalized 3-year citation impact, computed from OpenAlex with the NCI3 method. It divides the citations a journal’s papers received by the world average for papers of the same subfield, year and type, so 1.00 is the world average and 2.00 means twice as many citations as expected. Because it is normalized, it can be compared across fields. Read the methodology
- Quartiles
- Q1 to Q4 split the ranked journals of the list you are viewing into four equal groups by OJR. A journal’s quartile depends on the list: the same journal can be Q1 in its subfield and Q2 among all journals.
- Impact factor (2-year)
- Citations per paper over a two-year window, counted from OpenAlex. It is easy to compare with familiar impact factors but is not field-normalized, so compare it only within a field. It is not Clarivate’s Journal Impact Factor. Why it differs from the Journal Impact Factor
- Rank ranges
- Each rank in the latest year carries a likely range from 1,000 resamples of the journal’s papers. Where two journals’ ranges overlap, the data cannot tell them apart, so treat neighbouring ranks as ties.